Importantly, these assays might provide a more in-depth understanding of the complex mechanisms of acute rejection, chronic injury, and tolerance in organ transplantation, allowing the design of ...

If your body starts to reject the kidney, your doctor may be able to stop the rejection. But if not, you will need to have dialysis again. It is possible that you can have another transplant. You may ...

Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive biomarker that permits early diagnosis of antibody-mediated rejection (AMR) in kidney transplant recipients with de novo a ...

Kidney allograft rejection is the leading cause of graft failure in kidney transplant patients. Early identification and treatment of rejection is critical to reduce allograft injury and prevent ...

For example, no histological change has yet been identified to differentiate a clinical rejection resulting ... profiles in the urine sediments of kidney transplant patients provide information ...

BRISBANE, Calif., February 20, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and ...